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For a long time, the effects of distinct Eph tyrosine kinase receptors and their ligands, 
ephrins on the structure, immunophenotype, and development of thymus and their main 
cell components, thymocytes (T) and thymic epithelial cells (TECs), have been studied. In 
recent years, the thymic phenotype of mutant mice deficient in several Ephs and ephrins 
B has been determined. Remarkably, thymic stroma in these animals exhibits important 
defects that appear early in ontogeny but little alterations in the proportions of distinct 
lymphoid cell populations. In the present manuscript, we summarize and extend these 
results discussing possible mechanisms governing phenotypical and functional thymo-
cyte maturation in an absence of the critical T–TEC interactions, concluding that some 
signaling mediated by key molecules, such as MHCII, CD80, β5t, Aire, etc. could be 
sufficient to enable a proper maturation of thymocytes, independently of morphological 
alterations affecting thymic epithelium.
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iNtrODUctiON
The organogenesis of complex tissues requires the coordinated differentiation of cells at the correct 
time and place. A central role for Eph kinase receptors and their ligands, ephrins in these processes, 
has been claimed (1, 2) and, particularly, in the thymus (3). Both Eph and ephrins provide positional 
information for cells, regulating cell-to-cell contacts, cell migration, cell survival and differentiation. 
Eph receptors include EphA (10 members) that preferentially, but not exclusively, bind ephrins-A 
(6 members) and EphB (6 members) that interact with ephrins-B (3 members). In this system, Eph/
ephrin binding results in a bidirectional signaling, forward in the case of Eph and reverse in that of 
the ephrins (4). Both molecules that partially govern the establishment of the neural network in the 
central nervous system (5) also modulate the thymocyte migration throughout the thymic compart-
ments (6) and temporal and topological thymocyte (T)–thymic epithelial cell (TECs) interactions 
(3, 7). The relevance of such cell-to-cell interactions has been classically recognized, but some recent 
data question its importance (8). In the present analysis, we limit the relevance of T–TEC crosstalk 
to explain the absence of a clear thymocyte phenotype in thymi exhibiting a severely altered thymic 
epithelial network.
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tHe tHYMic PHeNOtYPe OF ephB-
DeFicieNt Mice
Phenotypes of thymocytes and TECs are remarkably different 
in EphB2 and EphB3 knockout thymi. Three major features 
characterize these thymi: hypocellularity, profound alterations in 
the morphology and histology of TECs, and few changes occur-
ring in the proportions of distinct thymocyte subpopulations. In 
addition, these phenotypes appear early in the thymus ontogeny 
and gradually increase when T–TEC interactions become more 
intense in WT thymi.
Absence of ephB2 and/or ephB3 courses 
With Low Number of Both thymocytes 
and tecs
The lack of Eph or ephrins courses with thymic hypocellularity 
that affect both thymocytes (9, 10) and TECs (11, 12), and the 
blockade of Eph/ephrin signaling reduces thymic cell numbers 
(13, 14).
Low numbers of recent emigrants seeding the mutant thymi 
and their slow maturation (10, 15) are a major cause of the thymic 
hypocellularity, in addition to their increased apoptosis and 
reduced proportions of cycling thymocytes (9). Reduced propor-
tions of cycling thymocytes could be associated with decreased 
Delta-like 4 (Dll4) and IL7 receptor α chain transcript (12) as 
is also observed in thymocytes exhibiting specific deletion of 
ephrin-B1 and ephrin-B2 (16), both molecules involved in the 
maturation of developing double-negative (DN) thymocytes (17, 
18).
Reduced lymphoid immigrants affect, by turn, the proportions 
of immature MTS20+ TECs (10) contributing to their delayed 
maturation and decreased TEC numbers. Also, altered propor-
tions of cycling TECs and apoptotic TECs account for TEC 
hypocellularity of mutant thymi (12). Fetal and postnatal thymi 
of EphB2- and/or EphB3-deficient mice show higher proportions 
of apoptotic TECs than WT ones, which correlates with a reduced 
thymic K8+ epithelial network (19). At E12.5, cell proliferation is 
delayed in Eph-deficient TECs as a consequence of the delayed 
seeding of lymphoid progenitor cells into mutant thymic primor-
dium (10, 12). Later, decreased proportions of cycling cells, which 
could be partially related to decreased transcripts of FGF7 and its 
receptor FGFR2IIIb (12) involved in thymic epithelium prolifera-
tion (20, 21), have been related with the delayed maturation of 
mutant thymic epithelium.
Delayed Maturation of tec subsets Also 
Occurs in ephB-Deficient thymi
Important morphological and immunohistochemical changes 
occur in the epithelial cell subpopulations of EphB-deficient 
thymi, including the presence of K5+K8+MTS10+ immature med-
ullary TECs (mTECs), high numbers of K5−K8−MTS20+ cells and 
K5+K8+ cortical TECs (cTECs) and increased number and size of 
K5−K8− epithelial-free areas (11, 22). By flow cytometry, we con-
firmed delayed maturation of immature MTS20+ TECs, cTECs 
defined by the expression of Ly51, CD205, MHCII, CD40 and β5t, 
and mTECs identified by UEA-1, Cld3/4, SSEA-1, MHCII, CD40, 
CD80, and Aire medullary markers (12, Montero-Herradón et al 
2017, submitted manuscript)1. This defective epithelial matura-
tion culminates in the aberrant phenotypes of mutant adult thymi, 
in which the 3D epithelial network is disrupted by the inability of 
thymocytes and TECs to adequately intermingle.
On the other hand, although it has been reported that the absence 
of one or several Eph has no phenotype because of the known prom-
iscuity of this molecular system, in which practically any Eph and 
ephrin can interact thus favoring a certain overlapping (23, 24), we 
recently demonstrated a specificity in the effects of EphB2 and EphB3 
on TECs. Remarkably, although both EphB2 and EphB3 are necessary 
for a proper development of both cortical and medullary epithelia, 
the lack of EphB2 results in a more severe medulla phenotype than 
that of EphB3−/− mTEC (Montero-Herradón et al 2017, submitted 
 manuscript)1, whereas the thymic cortex of EphB3−/− mice is particu-
larly affected (12).
Morphological changes in the Mutant tecs
The absence of EphB specifically affects the TEC morphology. 
In the medulla, mTECs undergo a shortening of cell processes 
appearing as globular cells in both EphB2−/− and EphB3−/− thymi, 
but in the cortex EphB2−/− cTECs show reduced cell processes 
resulting in a rounded cell shape, whereas EphB3−/− cTECs 
exhibit long, perpendicular cell processes. Independently of the 
changes undergone, mutant cells appear considerably separated 
from both thymocytes and other TECs (11). In order to confirm 
whether the lack of either EphB2 or EphB3 affected TEC shape, 
reaggregate thymus organ cultures (RTOCs) formed from WT 
fetal thymus lobes treated (or not) with either blocking anti-EphB2 
or anti-EphB3 antibodies were examined. In treated RTOCs, 
TEC morphology was similar to that of the respective mutant 
thymi: rounded in those treated with anti-EphB2 and exhibiting 
long, perpendicular cell processes in those receiving anti-EphB3 
(Figures 1A,B). In these conditions, epithelial cell processes were 
significantly shorter in both EphB2−/− or anti-EphB2-treated 
RTOCs and longer in EphB3−/− and anti-EphB3-treated RTOCs, 
than in WT RTOCs (Figures 1C,D).
It is largely known that the Eph/ephrin signaling modulates 
cytoskeleton and cell adhesion (25). More specifically, in RTOCs, 
the blockade of Eph signaling by soluble ephrin-B1Fc provokes 
TEC rounding with the disappearance of cell processes and 
disorganization of the cytoskeleton (13). In agreement, EphB2 
and EphB3 regulate the morphology of neuronal dendrite spines 
(26), the lack of ephrin-B2 elongates muscle cells and induces 
lamellipodium formation (27), and bone marrow-derived mesen-
chymal stromal cells treated with EphB2-Fc or EphB4-Fc fusion 
proteins undergo roundness and reduced size (28). It is evident, 
therefore, that morphological changes in TECs of EphB-deficient 
thymi hinder the establishment of proper cell-to-cell contacts 
between thymocytes and TECs, critical for the adequate matura-
tion of both thymic cell components, as previously indicated for 
the increased apoptotic TECs found in mutant thymi.
1 Montero-Herradon S, Garcia-Ceca J, Zapata AG. Delayed maturation of mTEC 
in EphB-deficient thymi is recovered by RANK signaling stimulation. Manuscript 
submitted (2017).
FigUre 1 | Thymic epithelial cell (TEC) morphology in reaggregate thymus organ cultures (RTOCs) established with either WT cells or EphB-deficient cells, or 
RTOCs treated with either blocking anti-EphB2 or anti-EphB3 antibodies. (A,B) Standard immunofluorescence study of the TEC network stained with an 
anti-PanCytokeratin antibody (PanCK, Green) and details of the TEC morphology in the different established RTOCs. Notice the shortened epithelial cell processes 
(arrows and insert dotted line) in RTOCs established with EphB2−/− cells (A) or treated with a blocking anti-EphB2 antibody (B) and the elongated cell processes 
(arrows and insert dotted line) in RTOCs established with EphB3−/− cells (A) or treated with anti-EphB3 antibody, as compared with their respective WT controls (A) 
or isotype control antibodies [(B), control]. The inserts illustrate the morphology of these cells. Scale: 50 µm. (c,D) Morphometric analysis of the length of cell 
processes in RTOCs established with either EphB2- or EphB3-deficient cells or RTOCs treated with blocking anti-EphB2 or anti-EphB3 antibodies. Note the 
reduced length of cell processes in RTOCs established with EphB2−/− cells (c) or treated with anti-EphB2 antibody (D), while those established with EphB3−/− cells 
(c) or treated with anti-EphB3 antibody (D) show longer cell processes as compared with their control RTOCs. The length of cell processes was measured in pixels 
in those cells whose cell body appeared sectioned. Five RTOCs of each experimental group were studied measuring about 25 cells and a total of 100–150 cell 
processes by reaggregate. The significance of the Student’s t-test probability is indicated as ***p ≤ 0.005.
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Histological Organization of thymic 
cortex and Medulla
In the thymic medulla of both fetal EphB2- and EphB3-deficient 
thymi, there are profound modifications that after birth, they 
remain in EphB2−/− medulla and improve partially in EphB3−/− 
thymi. Mature thymic medulla is organized from individual 
islets that expand and fuse after birth (29). By contrast, in mutant 
thymi, particularly in EphB2−/− ones, a unique adult thymic 
medulla is impaired and only small isolated foci remain. Adult 
EphB3-deficient thymi have a more organized central medulla but 
small, scattered medullary foci also appear (11). Furthermore, the 
quantification of these medullary foci in RTOCs established again 
with either WT, EphB2−/−, EphB3−-/−, blocking anti-EphB2- or 
anti-EphB3-treated fetal thymus lobes confirmed the existence of 
more and significantly smaller foci in mutant and treated lobes, 
with differences between those deficient in EphB2 and EphB3 
(Montero-Herradón et al 2017, submitted manuscript)1.
tHe cONDitiON OF t ceLLs iN  
ephB-DeFicieNt Mice
Although lower numbers of lymphoid progenitor cells seed 
both mutant adult and embryonic thymi than in WT mice (10, 
15), their subsequent progression does not result in notable 
changes in the percentages of distinct thymocyte subsets. Some 
delayed maturation of the DN cell subpopulations occurs with 
increased proportions of total DN cells and unchanged values of 
both double-positive (DP) cells and single-positive thymocytes. 
Within the DN cell populations, DN1 cells increased, whereas 
DN3 cell compartment underwent a significant reduction (9, 10). 
Decreased proportions of DN3 thymocytes could be associated 
with changes in TCR selection or molecules involved in their 
maturation, such as Dll4 and IL7 whose transcripts diminish in 
EphB-deficient thymi (12). In addition, Luo and colleagues (16) 
reported a reduced expression of the IL7 receptor α chain in 
ephrin-B1/ephrin-B2-deleted thymocytes.
On the other hand, analysis of the TCR repertoire of mutant 
CD4+ cells by using a battery of antibodies specific to different TCR 
rearrangements only found increased proportions of Vβ3+CD4+ 
cells in both thymus and lymph nodes (30), and the peripheral 
lymphoid organs (peripheral blood, spleen, lymph nodes) did 
not exhibit an altered architecture, a disturbed topological dis-
tribution of lymphoid and macrophage areas (30) nor significant 
changes in the proportions of CD4/CD8 T lymphocyte subpopu-
lations (9). Presumably, the mesenchyme-derived stroma of both 
spleen and lymph nodes is less affected than TECs by the lack of 
EphB. On the other hand, no changes occur in the proportions 
of TH1 (TCRαβ+CD4+IFNγ+), TH2 (TCRαβ+CD4+IL4+), and 
TH17 (TCRαβ+CD4+IL17+) cells between mutant and WT mice 
in either spleen or inguinal lymph nodes. Nor do the proportions 
of splenic TCRαβ+CD4+CD25+Foxp3+ Treg change when values 
of EphB2−/− (0.83 ± 0.25), EphB3−/− (0.72 ± 0.16), and WT mice 
(0.96 ± 0.27) are compared. By contrast, Treg of inguinal lymph 
nodes show significantly higher values in EphB2−/− (4.29 ± 0.40) 
and EphB3−/− mice (4.23 ± 0.44) than in WT ones (3.89 ± 0.45).
Recently, we evaluated other lymphoid cell populations 
particularly those involved in thymocyte selection within the 
thymus. No differences occurred in either positive selected 
TCRαβhiCD4+CD8+CD69+ and TCRαβhiCD4+CD8−CD69+ 
thymocytes in both EphB2- (3.00 ± 0.61; 8.00 ± 1.91) and EphB3 
(2.17 ± 0.40; 6.60 ± 1.73)-deficient thymi, as compared to WT 
values (2.47 ± 0.66; 7.09 ± 3.00). Nor did the percentage of both 
total TCRαβhiFoxp3+ and TCRαβhiCD4+Foxp3+ regulatory T cells 
(Treg) change when EphB2−/− mice (0.94 ± 0.06; 0.69 ± 0.10) and 
WT ones (0.90 ±  0.18; 0.66 ±  0.12) were compared, although 
values in EphB3−/− thymi were slightly lower, but not significantly, 
than in the other two mice analyzed (0.68 ± 0.07; 0.54 ± 0.04).
Negative selection was evaluated in WT and EphB-deficient mice 
comparing the proportions of total caspase3+CD5+CD69+CD4+ 
cells and Caspase3+CD5+CD69+CD4+CD8+ cells, as previously 
proposed (8, 31). No significant differences were observed in the pro-
portions of the two cell populations: Caspase3+CD5+CD69+CD4+ 
(WT: 0.035  ±  0.011; EphB2−/−: 0.026  ±  0.008; EphB3−/−: 
0.035  ±  0.013) and Caspase3+CD5+CD69+CD4+CD8+ (WT: 
0.031 ± 0.009; EphB2−/−: 0.039 ± 0.008; EphB3−/−: 0.020 ± 0.004). 
Mutant mice living in non-sterile conditions did not show appar-
ently immunological deficits (30) or any signs of autoimmunity 
since no substantial lymphoid infiltrates occur in their livers or 
salivary glands (unpublished data).
t-ceLL DeveLOPMeNt iN AN ALtereD 
tHYMic ePitHeLiUM
Taken together, these results confirm that, except for increased 
proportions of mutant DN thymocytes and lymph node Treg 
cells, the percentages of immunocompetent cells do not vary 
significantly in EphB-deficient animals. Nevertheless, more 
functional, in vivo approaches are necessary to definitively deter-
mine the immunological conditions of EphB-deficient animals. 
By contrast, the TEC network is deeply altered in these mutants 
making it difficult to explain how these changes do not affect 
thymocyte development since T–TEC interactions are considered 
critical for functional maturation of T cells (32, 33).
Results on the effects of Eph/ephrins on thymocyte matura-
tion are few and contradictory presumably reflecting different 
background of mutant mice, protocols used to evaluate effects 
of Eph/ephrins and/or specificity of molecules studied, as previ-
ously discussed (3). No anomalies have been described in mice 
with conditionally deleted EphB4 gene in TECs (34), deficiency 
in EphB6 (24), or in four Ephs, EphB1, B2, B3, and B6 (23). 
However, other authors have found poor in  vitro responses 
of EphB6−/− T  cells after anti-CD3 plus anti-CD28 stimula-
tion together as well as in  vivo decreased hypersensitivity and 
autoimmune responses (35). On the other hand, the deletion of 
either ephrin-B1 or ephrin-B2 in thymocytes does not course 
with thymus phenotypes (36, 37) but the lack of two molecules 
results in alterations in thymocytes and thymic structure (38), 
and low sensitivity to different autoimmune models, including 
experimental autoimmune encephalomyelitis (39) and collagen-
induced arthritis (40). We also observed decreased values of 
positive selected TCRαβhiCD69+ thymocytes in ephrin-B1 and/
or ephrin-B2 deleted in TECs, particularly when using outbred 
mouse strains. In this case, changes in these lymphoid subsets 
course with profound alterations in the histological thymus 
5Muñoz et al. T–TEC Crosstalk and EphB
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organization (41). In addition, the thymus of EphA4-deficient 
mice show reduced proportions of both DP TCRαβhi cells and 
CD69+ cells in correlation with the collapse of thymic cortex (42).
A first glance at these results could suggest a possible 
association with the pattern of Eph/ephrin expression. At the 
earliest stages of thymic development, when TEC predominates 
in T-cell numbers, the proportions of EphB2, EphB3, and ephrin-
B2-expressing cells rise to the highest values, sharply declining 
later, except for ephrin-B2+ cells that remain high until E14.5. 
Furthermore, in these early stages, the proportions of Eph/
ephrin B expressing TECs are significantly higher than those of 
eph/ephrin B+ thymocytes (12). It is tentative to speculate that a 
greater EphB-dependent effect could occur in cell types contain-
ing higher numbers of cells expressing these molecules.
Another important point is the condition of thymocyte-
TEC contacts in EphB-deficient thymi. Many features of these 
thymi do not favor the establishment of such interactions. Thus, 
increased proportions of apoptotic TECs and the appearance of 
huge epithelial-free areas make difficult thymocyte-TEC contacts 
in EphB-deficient mice (22). The point is to determine whether 
these changes are sufficient to provoke severe deficits in the 
molecular communications between thymocytes and TECs that 
result in holes in the T-cell repertoire or, by contrast, whether the 
remaining unchanged epithelial areas expressing key molecules 
for thymic functional selection, such as β5t, Aire, MHCII, and 
CD80 are capable of supporting an efficient T-cell maturation. 
Some recent results relating to the number and cell composition 
of thymic nurse complexes (TNCs) in EphB-deficient thymi con-
stitute an illustrative example of our hypothesis. Previously, we 
demonstrated impaired establishment of DP T–TEC conjugates 
derived from mutant thymi (13).
Thymic nurse complexes were first considered a kind 
of ex vivo specialized thymic microenvironment for T-cell 
maturation in which a single cTEC constituted lymphostro-
mal complexes with 7–50 thymocytes (43, 44). We analyzed 
comparatively TNCs (Figure 2A) isolated from either WT or 
EphB-deficient thymi, confirming the expression in them of 
cTEC (i.e., Ly51, CD205, CD40) markers and MHCII, but not 
of MTS20 or MTS10 typical molecules of immature cells and 
mTECs, respectively. Both epithelial cells and thymocytes of 
nurse complexes also express EphB2, EphB3, and their ligands, 
ephrin-B1 and ephrin-B2, but the number of complexes yielded 
from mutant thymi was significantly lower than those from WT 
ones (Figure 2B). Most isolated TNCs contained 6–10 thymo-
cytes and those composed of more than 21 thymocytes were 
the least represented. Mutant TNCs showed a similar range but 
exhibited significant reduced numbers of the most frequent 
ones containing 6–10 thymocytes (Figure  2C), suggesting 
that the lack of Eph/ephrin B affected the T–TEC interactions 
necessary to form the TNCs.
Although it is currently recognized that nurse complexes 
are special cortical areas involved in positive selection where 
long-lived DP thymocytes undergo secondary TCRα chain rear-
rangements (45), we failed to find changes in the proportions 
of positively selected TCRαβhiCD69+ thymocytes indirectly 
suggesting that alterations found in TNCs from EphB-deficient 
thymi are not sufficient to impair positive selection.
These results demonstrate therefore that mutant TECs 
express all the molecules necessary to interact with developing 
thymocytes and to promote their proper differentiation, although 
their appearance and maturation is delayed with respect to the 
WT epithelium (12, Montero-Herradón et al 2017, submitted 
manuscript)1. In this respect, it has been claimed that just a few 
unaltered areas of thymic stroma could be sufficient to support a 
quite normal T-cell development (21, 46). Conditional deletion of 
Stat3 in K5+ TEC that courses with changes in medulla histology 
and decreased proportions of mature MHCIIhiAire+ mTECs does 
not affect autoimmune reactivity (47). More recently, specific 
deletion in TECs of the LTβR gene produces important changes 
in mTECs, including the disruption of typical 3D medulla organi-
zation with small, scattered medulla foci, and reduced numbers 
of mTECslo, mTECshi, and Aire cells (8), quite similar to the 
phenotype described for the thymic medulla of EphB-deficient 
mice. However, the frequencies of CD4+ and CD8+ thymocytes 
FigUre 2 | Analysis of thymic nurse complexes (TNCs) in adult WT and EphB-deficient thymi. (A) Representative thymic nurse complex formed by thymic epithelial 
cells, stained with an anti-PanCytokeratin antibody (PanCK, Green) and thymocytes identified by using an anti-CD45 antibody (Red). Nuclei are stained with Hoechst 
33342 (Blue). Scale: 20 µm. (B) A significantly lower percentage of isolated TNC in EphB2−/− and EphB3−/− thymi than in WT ones. (c) According to the number of 
thymocytes included in the TNCs, six different groups could be established. The figure shows the TNC numbers of WT and EphB-deficient thymi after the analysis of 
30 TNCs. In both WT and mutant thymi, the distribution is similar but the frequency of those containing 6–10 thymocytes, which represent the half of total TNC 
analyzed, is lower in mutant than in WT ones. The significance of the Student’s t-test probability is indicated as *p ≤ 0.05. ns: non-significant.
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